# A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors

> **NCT06307795** · PHASE1 · RECRUITING · sponsor: **Avistone Biotechnology Co., Ltd.** · enrollment: 63 (estimated)

## Conditions studied

- Locally Advanced or Metastatic Solid Tumors

## Interventions

- **DRUG:** ANS014004

## Key facts

- **NCT ID:** NCT06307795
- **Lead sponsor:** Avistone Biotechnology Co., Ltd.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-24
- **Primary completion:** 2027-04
- **Final completion:** 2027-10
- **Target enrollment:** 63 (ESTIMATED)
- **Last updated:** 2026-04-17


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06307795

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06307795, "A Study to Investigate ANS014004 in Participants With Locally Advanced or Metastatic Solid Tumors". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT06307795. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*